NEVANAC IMPROVES CSME

Journal of Clinical Ophthalmology - Dove Medical Press:

The results from this small study suggests that nepafenac 0.1% may have activity against diabetic macular edema in a significant way.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH